Journal Title：Advances In Integrative Medicine

The Journal of Advances in Integrative Medicine is renowned for its high standards of scientific publication and rigorous review process. It adopts an international standard double-blind review system to ensure that each manuscript undergoes rigorous review by professional scholars and experts, ensuring the scientific, innovative, and reliable nature of its content. Its publication scope is extensive, covering multiple fields such as traditional Chinese and Western medicine and dietary therapy, joint research between traditional Chinese medicine and Western medicine, the latest developments in precision medicine, and the impact of genomics on disease prevention and treatment. It comprehensively focuses on the full lifecycle management of diseases, including new technologies, methods, and products related to disease occurrence and development, screening and early warning, diagnostic typing, treatment intervention, and prognosis.

In addition, the journal also focuses on the challenges and opportunities in the global health field, as well as the importance of equal access to healthcare for all, and is committed to promoting the development and popularization of integrated medicine on a global scale. Its international editorial team and open access publishing strategy further promote the widespread dissemination and collaborative exchange of academic achievements.

《綜合醫學的進展雜志》以高標準的科學發表和嚴格的審稿流程著稱，采用國際標準的雙盲評審制度，確保每篇稿件都經過專業學者和專家的嚴格審核，以保證內容的科學性、創新性和可靠性。其發表范圍廣泛，涵蓋中西藥與膳食療法、中醫與西醫聯合研究、精準醫學的最新發展、基因組學對疾病預防和治療的影響等多個領域，全面關注疾病的全生命周期管理，包括疾病的發生發展、篩查預警、診斷分型、治療干預及轉歸預后等方面的新技術、新方法和新產品。

此外，該期刊還關注全球衛生領域的挑戰和機遇，以及人人平等享有醫療保健的重要性，致力于推動綜合醫學在全球范圍內的發展與普及。其國際化的編委團隊和開放獲取的出版策略，進一步促進了學術成果的廣泛傳播與合作交流。

Advances In Integrative Medicine由Elsevier出版商出版，收稿方向涵蓋INTEGRATIVE & COMPLEMENTARY MEDICINE全領域，平均審稿速度 15 Weeks ，影響因子指數1.2，該期刊近期沒有被列入國際期刊預警名單，廣大學者值得一試。